Stelling, Adam
Stelling, Adam was paid $227K by Medicaid between Jun 2022 and Aug 2023, across 111 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 10% of everything it billed.
33Billing provider infoSTELLING, ADAM
RANCHO DOMINGUEZ, CA 90220
RANCHO DOMINGUEZ, CA 90220
33aNPI1659639417assigned 04/30/2012
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$227K
24GClaims151,364
24DCodes billed111
24AFirst – last monthJun 2022 – Aug 2023
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in California
Rank by total paid#24 of 315
Median peer was paid$3K
This provider vs. median79×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 75,531 | $114K | |
| 2023 | 75,833 | $112K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 10% | 12,824 | 9,734 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.5% | 16,058 | 10,219 | $21K |
| 87631 | 7.0% | 1,340 | 1,314 | $16K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.8% | 272 | 270 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.4% | 8,368 | 3,258 | $12K |
| 85027 | 3.9% | 8,027 | 3,856 | $9K | |
| 83735 | 3.1% | 5,576 | 2,060 | $7K | |
| 84145 | 2.6% | 1,343 | 968 | $6K | |
| 82803 | 2.5% | 1,914 | 1,489 | $6K | |
| 87040 | 2.4% | 1,795 | 1,421 | $6K | |
| 82330 | 2.4% | 1,942 | 1,369 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.4% | 1,435 | 916 | $5K |
99 more codes
| 84484 | 2.2% | 2,698 | $5K | |
| 83690 | 2.1% | 3,957 | $5K | |
| 83880 | 1.9% | 772 | $4K | |
| 84702 | 1.9% | 1,856 | $4K | |
| 82947 | 1.8% | 9,420 | $4K | |
| 80061 | Lipid panel | 1.8% | 1,735 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 1,335 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.6% | 2,183 | $4K |
| 84100 | 1.5% | 3,849 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 2,074 | $3K |
| 83970 | 1.2% | 400 | $3K | |
| 81001 | 1.2% | 4,861 | $3K | |
| 87077 | 1.1% | 1,101 | $2K | |
| 80202 | <1% | 843 | $2K | |
| 86901 | <1% | 4,086 | $2K | |
| 86900 | <1% | 4,087 | $2K | |
| 85730 | <1% | 1,216 | $2K | |
| 85610 | <1% | 2,200 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 388 | $2K |
| 86850 | <1% | 2,864 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 231 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 231 | $1K |
| 82570 | <1% | 1,526 | $1K | |
| 87186 | <1% | 794 | $1K | |
| 83605 | <1% | 759 | $1K | |
| 86803 | <1% | 525 | $1K | |
| 82728 | <1% | 687 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 256 | $1K |
| 86141 | <1% | 560 | $1K | |
| 81003 | <1% | 3,134 | $1K | |
| 87081 | <1% | 1,101 | $1K | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 920 | $1K |
| 80076 | <1% | 881 | $1K | |
| 83550 | <1% | 784 | $1K | |
| 82140 | <1% | 367 | $935.08 | |
| 83540 | <1% | 798 | $904.41 | |
| 87493 | <1% | 164 | $882.31 | |
| 87070 | <1% | 663 | $875.48 | |
| 87340 | <1% | 462 | $818.26 | |
| 84550 | <1% | 999 | $796.42 | |
| 85379 | <1% | 433 | $768.60 | |
| 82043 | <1% | 754 | $763.41 | |
| 86880 | <1% | 783 | $760.76 | |
| 84156 | <1% | 1,138 | $732.64 | |
| 82247 | <1% | 744 | $731.10 | |
| 87205 | <1% | 837 | $704.10 | |
| 84703 | <1% | 762 | $689.83 | |
| 80074 | <1% | 68 | $588.69 | |
| 88304 | <1% | 24 | $580.49 | |
| 87075 | <1% | 372 | $547.71 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 616 | $507.97 |
| 87149 | <1% | 43 | $481.00 | |
| 87210 | <1% | 624 | $457.24 | |
| 84132 | <1% | 2,418 | $383.27 | |
| 84439 | <1% | 245 | $382.28 | |
| 81025 | <1% | 2,065 | $374.88 | |
| 85652 | <1% | 653 | $310.87 | |
| 88342 | <1% | 12 | $301.21 | |
| 86140 | <1% | 314 | $288.21 | |
| 82550 | <1% | 202 | $281.25 | |
| 87015 | <1% | 206 | $259.86 | |
| 82040 | <1% | 481 | $235.77 | |
| 82150 | <1% | 206 | $234.24 | |
| 83615 | <1% | 212 | $221.12 | |
| 86038 | <1% | 30 | $189.97 | |
| 89051 | <1% | 46 | $171.16 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 131 | $159.79 |
| 87102 | <1% | 84 | $151.57 | |
| 86870 | <1% | 33 | $133.32 | |
| 87116 | <1% | 65 | $132.64 | |
| 85384 | <1% | 81 | $121.96 | |
| 84295 | <1% | 1,778 | $114.89 | |
| 85018 | <1% | 1,993 | $91.74 | |
| 82607 | <1% | 59 | $87.82 | |
| 82435 | <1% | 1,694 | $87.27 | |
| 87206 | <1% | 81 | $78.99 | |
| 84478 | <1% | 79 | $76.00 | |
| 82746 | <1% | 28 | $73.08 | |
| 84480 | <1% | 25 | $63.00 | |
| 86706 | <1% | 33 | $62.70 | |
| 86780 | <1% | 27 | $59.05 | |
| 82270 | <1% | 101 | $57.89 | |
| 80197 | <1% | 27 | $56.12 | |
| 82465 | <1% | 65 | $50.05 | |
| 82248 | <1% | 49 | $45.40 | |
| 84520 | <1% | 463 | $42.21 | |
| 85014 | <1% | 293 | $37.92 | |
| 84300 | <1% | 45 | $34.73 | |
| 80047 | <1% | 29 | $34.23 | |
| 84436 | <1% | 26 | $31.46 | |
| 85046 | <1% | 32 | $29.44 | |
| 84540 | <1% | 43 | $28.38 | |
| 82010 | <1% | 12 | $16.48 | |
| 87899 | <1% | 16 | $1.56 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 732 | $0.00 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 66 | $0.00 |
| 81050 | 0% | 32 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 89 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 104 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.